Rare disease research suffers because individual investigators are unlikely to propose studies on conditions affecting small populations unless NIH signals it is a priority and has dedicated funding. Research on health disparities struggles for the same reason. Studies requiring particular methodologies, specific patient populations, or coordination across multiple sites all depend on NOFOs that describe exactly what NIH is looking for and commit resources to support it.

Emerging threats become harder to address quickly. When COVID-19 emerged, NIH issued emergency funding announcements within weeks. Those NOFOs allowed the agency to mobilize researchers rapidly toward specific problems: vaccine development, therapeutic testing, long-term effects, vulnerable populations. Without the ability to issue targeted calls, response to future health emergencies will be slower and less coordinated.

...

you are viewing a single comment's thread
view the rest of the comments

[–] phoenixz@lemmy.ca 3 points 22 hours ago (1 children)

America isn't dying, it dies a while ago and is just having some spasms.

This is the USA killing their scientific branch. All scientists walk away, like they did when the Nazi's came into power.

Canada and Europe should welcome them all with open arms

[–] SaveTheTuaHawk@lemmy.ca 4 points 21 hours ago

What? We barely fund 9% of research applications in Canada. Welcoming scientists to do what, be barristas?

Carney is spending tens of billions on war machines while we spend 0.2% of healthcare spending on research. We will be spending more on parking F35s unused than all the biomedical research in Canada per year.

I don't think people get it. No research is no hope, no new drugs, no ways to prevent disease.